Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma

BACKGROUND. Conflicting data exist regarding the prognostic impact of the isocitrate dehydrogenase (IDH) mutation in intrahepatic cholangiocarcinoma (ICC), and limited data exist in patients with advanced-stage disease. Similarly, the clinical phenotype of patients with advanced IDH mutant (IDHm) IC...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncologist
Главные авторы: Goyal, Lipika, Govindan, Aparna, Sheth, Rahul A., Nardi, Valentina, Blaszkowsky, Lawrence S., Faris, Jason E., Clark, Jeffrey W., Ryan, David P., Kwak, Eunice L., Allen, Jill N., Murphy, Janet E., Saha, Supriya K., Hong, Theodore S., Wo, Jennifer Y., Ferrone, Cristina R., Tanabe, Kenneth K., Chong, Dawn Q., Deshpande, Vikram, Borger, Darrell R., Iafrate, A. John, Bardeesy, Nabeel, Zheng, Hui, Zhu, Andrew X.
Формат: Artigo
Язык:Inglês
Опубликовано: AlphaMed Press 2015
Предметы:
Gastrointestinal Cancer
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4571807/
https://ncbi.nlm.nih.gov/pubmed/26245674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0210
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы